Manning; Pamela T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Manning; Pamela T..The latest application filed is for "biomarkers to improve efficacy of cancer immunotherapy".
Company Profile
14.15.36
- Manning; Pamela T. - St. Louis MO
- MANNING; Pamela T. - Chesterfield MO
- Manning; Pamela T. - Labadie MO
Patent Activity
| Patent | Date |
|---|---|
| Therapeutic CD47 antibodies Grant 11,292,834 - Frazier , et al. April 5, 2 | 2022-04-05 |
| Biomarkers To Improve Efficacy Of Cancer Immunotherapy App 20210395831 - CAPOCCIA; Benjamin J. ; et al. | 2021-12-23 |
| Therapeutic Cd47 Antibodies App 20210324075 - PURO; Robyn ; et al. | 2021-10-21 |
| Therapeutic Cd47 Antibodies App 20210079091 - MANNING; Pamela T. ; et al. | 2021-03-18 |
| Therapeutic Cd47 Antibodies App 20210070865 - MANNING; Pamela T. ; et al. | 2021-03-11 |
| Therapeutic CD47 antibodies Grant 10,844,124 - Manning , et al. November 24, 2 | 2020-11-24 |
| THERAPEUTIC SIRP-alpha ANTIBODIES App 20200297842 - PURO; Robyn ; et al. | 2020-09-24 |
| Therapeutic CD47 antibodies Grant 10,676,524 - Frazier , et al. | 2020-06-09 |
| Therapeutic CD47 antibodies Grant 10,669,336 - Frazier , et al. | 2020-06-02 |
| Therapeutic Cd47 Antibodies App 20200095318 - MANNING; Pamela T. ; et al. | 2020-03-26 |
| Combination Therapy For The Treatment Of Solid And Hematological Cancers App 20190309066 - MANNING; Pamela T. ; et al. | 2019-10-10 |
| Therapeutic Cd47 Antibodies App 20190300611 - MANNING; Pamela T. ; et al. | 2019-10-03 |
| Therapeutic Cd47 Antibodies App 20190248892 - Frazier; William A. ; et al. | 2019-08-15 |
| Therapeutic Cd47 Antibodies App 20190112373 - Manning; Pamela T. ; et al. | 2019-04-18 |
| Therapeutic CD47 antibodies Grant 10,259,873 - Frazier , et al. | 2019-04-16 |
| Therapeutic CD47 antibodies Grant 10,239,945 - Manning , et al. | 2019-03-26 |
| Therapeutic Cd47 Antibodies App 20180171014 - MANNING; Pamela T. ; et al. | 2018-06-21 |
| Therapeutic Cd47 Antibodies App 20180142019 - MANNING; Pamela T. ; et al. | 2018-05-24 |
| Therapeutic Cd47 Antibodies App 20180057592 - FRAZIER; William A. ; et al. | 2018-03-01 |
| Therapeutic Cd47 Antibodies App 20180051081 - FRAZIER; William A. ; et al. | 2018-02-22 |
| Therapeutic Cd47 Antibodies App 20170283498 - Frazier; William A. ; et al. | 2017-10-05 |
| Therapeutic CD47 antibodies Grant 9,518,116 - Frazier , et al. December 13, 2 | 2016-12-13 |
| Therapeutic CD47 antibodies Grant 9,518,117 - Frazier , et al. December 13, 2 | 2016-12-13 |
| Therapeutic Cd47 Antibodies App 20160137734 - Frazier; William A. ; et al. | 2016-05-19 |
| Therapeutic Cd47 Antibodies App 20160137733 - Frazier; William A. ; et al. | 2016-05-19 |
| Therapeutic CD47 antibodies Grant 9,221,908 - Frazier , et al. December 29, 2 | 2015-12-29 |
| Therapeutic Cd47 Antibodies App 20150274826 - FRAZIER; William A. ; et al. | 2015-10-01 |
| Therapeutic Cd47 Antibodies App 20140363442 - FRAZIER; William A. ; et al. | 2014-12-11 |
| Therapeutic CD47 Antibodies App 20140161799 - Frazier; William A. ; et al. | 2014-06-12 |
| Amidino compounds useful as nitric oxide synthase inhibitors Grant 7,196,118 - Webber , et al. March 27, 2 | 2007-03-27 |
| Methods of making amidino compounds useful as nitric oxide synthase inhibitors Grant 7,102,013 - Webber , et al. September 5, 2 | 2006-09-05 |
| Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers Grant 7,012,098 - Manning , et al. March 14, 2 | 2006-03-14 |
| Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents App 20050203082 - Hsu, Chung Y. ; et al. | 2005-09-15 |
| Amidino compounds useful as nitric oxide synthase inhibitors App 20050165106 - Webber, Ronald Keith ; et al. | 2005-07-28 |
| Amidino compounds useful as nitric oxide synthase inhibitors Grant 6,914,158 - Webber , et al. July 5, 2 | 2005-07-05 |
| Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith App 20050113409 - Connor, Jane R. ; et al. | 2005-05-26 |
| Amidino compounds useful as nitric oxide synthase inhibitors App 20040186178 - Webber, Ronald Keith ; et al. | 2004-09-23 |
| Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors App 20040143017 - Manning, Pamela T. ; et al. | 2004-07-22 |
| Methods for treatment and prevention of gastrointestinal conditions App 20040127569 - Manning, Pamela T. ; et al. | 2004-07-01 |
| Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor App 20040087653 - Manning, Pamela T. | 2004-05-06 |
| Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor App 20040077639 - Manning, Pamela T. | 2004-04-22 |
| Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors Grant 6,653,350 - Manning , et al. November 25, 2 | 2003-11-25 |
| Methods of making amidino compounds useful as nitric oxide synthase inhibitors App 20030199701 - Webber, Ronald Keith ; et al. | 2003-10-23 |
| Amidino compounds useful as nitric oxide synthase inhibitors Grant 6,586,474 - Webber , et al. July 1, 2 | 2003-07-01 |
| Neuroprotective treatment methods using selective iNOS inhibitors App 20030119826 - Manning, Pamela T. ; et al. | 2003-06-26 |
| Ophthalmologic treatment methods using selective iNOS inhibitors App 20030109522 - Manning, Pamela T. ; et al. | 2003-06-12 |
| Agents and methods for treatment of cancer App 20030013702 - Manning, Pamela T. ; et al. | 2003-01-16 |
| Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors App 20020049202 - Grapperhaus, Margaret L. ; et al. | 2002-04-25 |
| Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors App 20020037927 - Hansen, Donald W. JR. ; et al. | 2002-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 